Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.
An implementation framework for difficult-to-manage and complex-to-manage psoriatic arthritis proposes dual-denominator prevalence reporting and mechanism-aware phenotypes to improve reproducibility.
True treatment non-response in spondyloarthritis is heterogeneous, with four distinct clinical patterns—primary non-response, secondary loss of response, divergent domain responses, and paradoxical reactions—shaped by drug exposure and compartmentalization.
Ixekizumab plus tirzepatide maintained and expanded psoriatic arthritis control through week 52, with simultaneous ACR50 and ≥10% weight reduction rising to 39.2% vs 1.7%.